BB
Benjamin Burnett Wells Fargo Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
38
Avg Return
Past Year
Past Year
8.3%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
81.3%
Neutral
18.8%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $46 |
16%
upside
| 2 | +3.7% |
0
%
| 11 Mar ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $68 |
14%
upside
| 2 | +8.1% |
0
%
| 10 Mar ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $44 |
11%
upside
| 1 | +2.9% |
0
%
| 6 Mar ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $20 |
71%
upside
| 1 | -20% |
0
%
| 5 Mar ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $30 |
31%
upside
| 1 | -27% |
0
%
| 27 Feb ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $7 |
146%
upside
| 1 | -27% |
0
%
| 27 Feb ‘26 1 month ago |
|
|
|
Equal-Weight
Maintained
| $466 |
21%
downside
| 1 | – |
–
| 26 Feb ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $43 |
25%
upside
| 1 | -1.1% |
0
%
| 26 Feb ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $202 |
7%
upside
| 2 | +7.5% |
0
%
| 24 Feb ‘26 1 month ago |
|
|
|
Equal-Weight
Maintained
| $305 |
11%
downside
| 2 | – |
–
| 20 Feb ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $86 |
19%
upside
| 1 | -0.74% |
0
%
| 20 Feb ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $208 |
44%
upside
| 2 | -15% |
0
%
| 20 Feb ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $27 |
260%
upside
| 1 | +43% |
0
%
| 12 Feb ‘26 2 months ago |
|